VYLEESI (AUTOINJECTOR) Drug Patent Profile
✉ Email this page to a colleague
When do Vyleesi (autoinjector) patents expire, and what generic alternatives are available?
Vyleesi (autoinjector) is a drug marketed by Cosette and is included in one NDA. There are five patents protecting this drug.
This drug has eighty-one patent family members in twenty-six countries.
The generic ingredient in VYLEESI (AUTOINJECTOR) is bremelanotide acetate. One supplier is listed for this compound. Additional details are available on the bremelanotide acetate profile page.
DrugPatentWatch® Generic Entry Outlook for Vyleesi (autoinjector)
Vyleesi (autoinjector) was eligible for patent challenges on June 21, 2023.
Indicators of Generic Entry
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for VYLEESI (AUTOINJECTOR)?
- What are the global sales for VYLEESI (AUTOINJECTOR)?
- What is Average Wholesale Price for VYLEESI (AUTOINJECTOR)?
Summary for VYLEESI (AUTOINJECTOR)
International Patents: | 81 |
US Patents: | 5 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 1 |
DailyMed Link: | VYLEESI (AUTOINJECTOR) at DailyMed |
Pharmacology for VYLEESI (AUTOINJECTOR)
Drug Class | Melanocortin Receptor Agonist |
Mechanism of Action | Melanocortin Receptor Agonists |
US Patents and Regulatory Information for VYLEESI (AUTOINJECTOR)
VYLEESI (AUTOINJECTOR) is protected by five US patents and one FDA Regulatory Exclusivity.
Patents protecting VYLEESI (AUTOINJECTOR)
Uses of bremelanotide in therapy for female sexual dysfunction
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Patented Use: TREATMENT OF HYPOACTIVE SEXUAL DESIRE DISORDER (HSDD)
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Patented Use: TREATING ACQUIRED, GENERALIZED HYPOACTIVE SEXUAL DESIRE DISORDER (HSDD) IN A PREMENOPAUSAL FEMALE PATIENT WITH CONTROLLED HYPERTENSION BY INJECTING BREMELANOTIDE MORE THAN ONCE WITH AT LEAST 24 HOURS BETWEEN DOSES AND NO MORE THAN 8 DOSES PER MONTH
Compositions and methods for treatment of sexual dysfunction
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Uses of bremelanotide in therapy for female sexual dysfunction
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Patented Use: TREATMENT OF HYPOACTIVE SEXUAL DESIRE DISORDER (HSDD)
Uses of bremelanotide in therapy for female sexual dysfunction
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Patented Use: TREATMENT OF HYPOACTIVE SEXUAL DESIRE DISORDER (HSDD)
FDA Regulatory Exclusivity protecting VYLEESI (AUTOINJECTOR)
NEW CHEMICAL ENTITY
Exclusivity Expiration: ⤷ Sign Up
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cosette | VYLEESI (AUTOINJECTOR) | bremelanotide acetate | SOLUTION;SUBCUTANEOUS | 210557-001 | Jun 21, 2019 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Cosette | VYLEESI (AUTOINJECTOR) | bremelanotide acetate | SOLUTION;SUBCUTANEOUS | 210557-001 | Jun 21, 2019 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Cosette | VYLEESI (AUTOINJECTOR) | bremelanotide acetate | SOLUTION;SUBCUTANEOUS | 210557-001 | Jun 21, 2019 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Cosette | VYLEESI (AUTOINJECTOR) | bremelanotide acetate | SOLUTION;SUBCUTANEOUS | 210557-001 | Jun 21, 2019 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Cosette | VYLEESI (AUTOINJECTOR) | bremelanotide acetate | SOLUTION;SUBCUTANEOUS | 210557-001 | Jun 21, 2019 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Cosette | VYLEESI (AUTOINJECTOR) | bremelanotide acetate | SOLUTION;SUBCUTANEOUS | 210557-001 | Jun 21, 2019 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | Y | Y | ⤷ Sign Up | ||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for VYLEESI (AUTOINJECTOR)
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Cosette | VYLEESI (AUTOINJECTOR) | bremelanotide acetate | SOLUTION;SUBCUTANEOUS | 210557-001 | Jun 21, 2019 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for VYLEESI (AUTOINJECTOR)
See the table below for patents covering VYLEESI (AUTOINJECTOR) around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Hong Kong | 1047881 | ⤷ Sign Up | |
European Patent Office | 1755638 | ⤷ Sign Up | |
South Korea | 102253526 | ⤷ Sign Up | |
Israel | 238276 | תכשיר המכיל ברמלנוטיד לשימוש בטיפול באי תפקוד מיני נשי (A composituon comprising bremelanotide for use in treating female sexual dysfunction) | ⤷ Sign Up |
Germany | 60019598 | ⤷ Sign Up | |
Brazil | 112015009936 | método para tratar disfunção sexual feminina em uma paciente do sexo feminino diagnosticada com disfunção sexual feminina, mas desejando ter atividade sexual; uso de uma dose de formulação; bremelanotide para uso em um método para tratar disfunção sexual feminina; e unidade de dose pré-carregada | ⤷ Sign Up |
European Patent Office | 1441750 | ⤷ Sign Up | |
>Country | >Patent Number | >Title | >Estimated Expiration |